BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

921 related articles for article (PubMed ID: 27225918)

  • 1. [Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].
    Genser L; Poitou C; Brot-Laroche É; Rousset M; Vaillant JC; Clément K; Thenet S; Leturque A
    Med Sci (Paris); 2016 May; 32(5):461-9. PubMed ID: 27225918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.
    Bleau C; Karelis AD; St-Pierre DH; Lamontagne L
    Diabetes Metab Res Rev; 2015 Sep; 31(6):545-61. PubMed ID: 25352002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity-Linked Gut Microbiome Dysbiosis Associated with Derangements in Gut Permeability and Intestinal Cellular Homeostasis Independent of Diet.
    Nagpal R; Newman TM; Wang S; Jain S; Lovato JF; Yadav H
    J Diabetes Res; 2018; 2018():3462092. PubMed ID: 30250849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOS/GOS attenuates high-fat diet induced bone loss via reversing microbiota dysbiosis, high intestinal permeability and systemic inflammation in mice.
    Zhang Z; Lin T; Meng Y; Hu M; Shu L; Jiang H; Gao R; Ma J; Wang C; Zhou X
    Metabolism; 2021 Jun; 119():154767. PubMed ID: 33753088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gut microbiota: Description, role and pathophysiologic implications].
    Landman C; Quévrain E
    Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of dietary fat on gut microbiota and low-grade systemic inflammation: mechanisms and clinical implications on obesity.
    Cândido FG; Valente FX; Grześkowiak ŁM; Moreira APB; Rocha DMUP; Alfenas RCG
    Int J Food Sci Nutr; 2018 Mar; 69(2):125-143. PubMed ID: 28675945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiome and Obesity: A Plausible Explanation for Obesity.
    Sanmiguel C; Gupta A; Mayer EA
    Curr Obes Rep; 2015 Jun; 4(2):250-61. PubMed ID: 26029487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, fatty liver disease and intestinal microbiota.
    Arslan N
    World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
    Amabebe E; Robert FO; Agbalalah T; Orubu ESF
    Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
    Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance.
    Escobedo G; López-Ortiz E; Torres-Castro I
    Rev Invest Clin; 2014; 66(5):450-9. PubMed ID: 25695388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota.
    Chang CJ; Lin CS; Lu CC; Martel J; Ko YF; Ojcius DM; Tseng SF; Wu TR; Chen YY; Young JD; Lai HC
    Nat Commun; 2015 Jun; 6():7489. PubMed ID: 26102296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Laparoscopic Sleeve Gastrectomy on Gut Permeability in Morbidly Obese Subjects.
    Kellerer T; Brandl B; Büttner J; Lagkouvardos I; Hauner H; Skurk T
    Obes Surg; 2019 Jul; 29(7):2132-2143. PubMed ID: 30903427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis.
    Jiao N; Baker SS; Nugent CA; Tsompana M; Cai L; Wang Y; Buck MJ; Genco RJ; Baker RD; Zhu R; Zhu L
    Physiol Genomics; 2018 Apr; 50(4):244-254. PubMed ID: 29373083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota and Obesity.
    Isolauri E
    Nestle Nutr Inst Workshop Ser; 2017; 88():95-105. PubMed ID: 28346926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connection between gut microbiome and the development of obesity.
    Zhi C; Huang J; Wang J; Cao H; Bai Y; Guo J; Su Z
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):1987-1998. PubMed ID: 31367997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond gut microbiota: understanding obesity and type 2 diabetes.
    Lau E; Carvalho D; Pina-Vaz C; Barbosa JA; Freitas P
    Hormones (Athens); 2015; 14(3):358-69. PubMed ID: 26188221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.